PPARG and Insulin resistance: Insulin resistance is an important aspect of PCOS and has been observed not only in obese but also in lean women with PCOS and seems to be an intrinsic part of the syndrome [12, 13]; PPAR-γ agonists can decrease androgen synthesis in ovaries by ameliorating peripheral insulin resistance indirectly [14].